| scholarly article | Q13442814 |
| P50 | author | Tamar R Aprahamian | Q39361982 |
| Kenneth Walsh | Q42730508 | ||
| Michael T Kirber | Q43008273 | ||
| P2093 | author name string | Rei Shibata | |
| Noriyuki Ouchi | |||
| Shinji Kihara | |||
| Yukihiro Takemura | |||
| Ross S Summer | |||
| P2860 | cites work | Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages | Q24290146 |
| Cloning of adiponectin receptors that mediate antidiabetic metabolic effects | Q24304889 | ||
| T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin | Q24564272 | ||
| C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells | Q24670661 | ||
| Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 | ||
| The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity | Q28506782 | ||
| Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 | Q28511676 | ||
| Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte | Q29615441 | ||
| Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity | Q29616103 | ||
| Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling | Q31056825 | ||
| Adiponectin-mediated modulation of hypertrophic signals in the heart | Q33688678 | ||
| Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms | Q33688706 | ||
| Identification of amino-terminal region of adiponectin as a physiologically functional domain | Q82242830 | ||
| Interaction of mutant lpr gene with background strain influences renal disease | Q93612765 | ||
| A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo | Q33912964 | ||
| Phagocytosis and clearance of apoptotic cells is mediated by MER. | Q33946282 | ||
| A blast from the past: clearance of apoptotic cells regulates immune responses. | Q34162195 | ||
| cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). | Q34377772 | ||
| Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease | Q34602392 | ||
| The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice | Q35108391 | ||
| Obesity, adiponectin and vascular inflammatory disease | Q35587168 | ||
| Cholesterol-dependent clustering of IL-2Ralpha and its colocalization with HLA and CD48 on T lymphoma cells suggest their functional association with lipid rafts. | Q35757313 | ||
| Regulation of insulin sensitivity by adipose tissue-derived hormones and inflammatory cytokines | Q35786203 | ||
| Immunoregulatory functions of surfactant proteins | Q35998804 | ||
| A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? | Q36081354 | ||
| TNF pathophysiology in murine models of chronic inflammation and autoimmunity. | Q36106345 | ||
| Adipose tissue, inflammation, and cardiovascular disease | Q36125401 | ||
| Abnormalities induced by the mutant gene, lpr. Patterns of disease and expression of murine leukemia viruses in SJL/J mice homozygous and heterozygous for lpr. | Q36349884 | ||
| Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease | Q36399434 | ||
| Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex | Q39750562 | ||
| Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes | Q40892075 | ||
| Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages | Q42117845 | ||
| Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response. | Q42231394 | ||
| AdipoQ is a novel adipose-specific gene dysregulated in obesity | Q42813232 | ||
| Adiponectin and protection against type 2 diabetes mellitus | Q44290932 | ||
| Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. | Q44453195 | ||
| Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation | Q44457586 | ||
| Increased single-nephron protein excretion after renal ablation in nephrotic rats | Q46433944 | ||
| Human adiponectin binds to bacterial lipopolysaccharide | Q46907520 | ||
| Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages | Q47735588 | ||
| Association between adiponectin and mediators of inflammation in obese women. | Q48007188 | ||
| Decreased phagocytosis of apoptotic cells in diseased SLE mice | Q48029935 | ||
| Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. | Q54790389 | ||
| Lupus-Prone Mice Have an Abnormal Response to Thioglycolate and an Impaired Clearance of Apoptotic Cells | Q57089503 | ||
| Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies | Q57089602 | ||
| Immunosuppressive effects of apoptotic cells | Q59060221 | ||
| Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice | Q64378290 | ||
| Lipopolysaccharide induces rapid production of IL-10 by monocytes in the presence of apoptotic neutrophils | Q77584477 | ||
| Inhibition by adiponectin of IL-8 production by human macrophages upon coculturing with late apoptotic cells | Q80416626 | ||
| Inverse association between adiponectin and C-reactive protein in substantially healthy Japanese men | Q81570063 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| apoptotic process | Q14599311 | ||
| P304 | page(s) | 375-386 | |
| P577 | publication date | 2007-01-25 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies | |
| P478 | volume | 117 |
| Q37326561 | Adipocytokines and liver disease |
| Q27021977 | Adipocytokines and obesity-linked disorders |
| Q38810625 | Adipocytokines in Cardiovascular and Metabolic Diseases |
| Q30357655 | Adipocytokines in obesity and metabolic disease. |
| Q33593028 | Adipokine Contribution to the Pathogenesis of Osteoarthritis. |
| Q29620456 | Adipokines in inflammation and metabolic disease |
| Q36920864 | Adipokines mediate inflammation and insulin resistance |
| Q33785169 | Adipokines, insulin resistance, and coronary artery calcification |
| Q37707281 | Adipokines: a link between obesity and cardiovascular disease. |
| Q97536490 | Adiponectin Stimulates Exosome Release to Enhance Mesenchymal Stem-Cell-Driven Therapy of Heart Failure in Mice |
| Q35971216 | Adiponectin action: a combination of endocrine and autocrine/paracrine effects. |
| Q38422695 | Adiponectin ameliorates doxorubicin-induced cardiotoxicity through Akt protein-dependent mechanism |
| Q37798714 | Adiponectin and Hypertension |
| Q30358456 | Adiponectin and cardiovascular disease: state of the art? |
| Q50971412 | Adiponectin and cardiovascular outcomes among hemodialysis patients. |
| Q38465754 | Adiponectin and its receptor signaling: an anti-cancer therapeutic target and its implications for anti-tumor immunity |
| Q26821925 | Adiponectin as a potential biomarker of vascular disease |
| Q33910404 | Adiponectin attenuates abdominal aortic aneurysm formation in hyperlipidemic mice |
| Q35658773 | Adiponectin attenuates lipopolysaccharide-induced acute lung injury through suppression of endothelial cell activation |
| Q37353726 | Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling |
| Q36877056 | Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality |
| Q33654259 | Adiponectin deficiency promotes tumor growth in mice by reducing macrophage infiltration |
| Q33511929 | Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure |
| Q37337539 | Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease. |
| Q46475489 | Adiponectin exerts cardioprotection against ischemia/reperfusion injury partially via calreticulin mediated anti-apoptotic and anti-oxidative actions |
| Q35316632 | Adiponectin expression and the cardioprotective role of the vitamin D receptor activator paricalcitol and the angiotensin converting enzyme inhibitor enalapril in ApoE-deficient mice |
| Q52898823 | Adiponectin expression in patients with inflammatory cardiomyopathy indicates favourable outcome and inflammation control. |
| Q35219362 | Adiponectin in cardiovascular inflammation and obesity |
| Q37164707 | Adiponectin in inflammatory and immune-mediated diseases |
| Q36714296 | Adiponectin in pulmonary disease and critically ill patients |
| Q34919154 | Adiponectin inhibits neutrophil phagocytosis of Escherichia coli by inhibition of PKB and ERK 1/2 MAPK signalling and Mac-1 activation |
| Q33509887 | Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study |
| Q34150591 | Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages |
| Q33673519 | Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype |
| Q37233419 | Adiponectin promotes revascularization of ischemic muscle through a cyclooxygenase 2-dependent mechanism |
| Q34557564 | Adiponectin provides cardiovascular protection in metabolic syndrome |
| Q54574744 | Adiponectin receptor 1 interacts with both subunits of protein kinase CK2. |
| Q35041976 | Adiponectin receptor signaling on dendritic cells blunts antitumor immunity |
| Q39823640 | Adiponectin reduces C-reactive protein expression and downregulates STAT3 phosphorylation induced by IL-6 in HepG2 cells |
| Q36920314 | Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1. |
| Q34592720 | Adiponectin regulates vascular endothelial growth factor-C expression in macrophages via Syk-ERK pathway |
| Q26753354 | Adiponectin signaling and function in insulin target tissues |
| Q37339479 | Adiponectin suppresses pathological microvessel formation in retina through modulation of tumor necrosis factor-alpha expression |
| Q35061908 | Adiponectin, a key adipokine in obesity related liver diseases |
| Q93048682 | Adiponectin/AdipoR Research and Its Implications for Lifestyle-Related Diseases |
| Q26753340 | Adiponectin: a versatile player of innate immunity |
| Q44579218 | Adiponectin: an enlarging role in acute kidney injury |
| Q92854261 | Adipose Tissue, Obesity and Adiponectin: Role in Endocrine Cancer Risk |
| Q46821191 | Ageing is associated with diminished apoptotic cell clearance in vivo |
| Q36619374 | Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice |
| Q34429536 | Association between adipokines and coronary artery lesions in children with Kawasaki Disease |
| Q35893643 | Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients |
| Q50053611 | Association of abnormal glucose metabolism and insulin resistance in patients with atypical and typical endometrial cancer |
| Q31146255 | Association of adiponectin with peripheral arterial disease and mortality in nondiabetic hemodialysis patients: Long-term follow-up data of 7 years |
| Q43522114 | Beneficial effects of grape resveratrol on serum adiponectin and inflammation: clinical trial in patients with stable coronary artery disease: editorial to: "Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in perip |
| Q36444135 | C1q Deficiency Promotes Pulmonary Vascular Inflammation and Enhances the Susceptibility of the Lung Endothelium to Injury |
| Q37624585 | CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). |
| Q47395250 | CTRP9 Regulates Growth, Differentiation, and Apoptosis in Human Keratinocytes through TGFβ1-p38-Dependent Pathway. |
| Q89820632 | Calreticulin Blockade Attenuates Murine Acute Lung Injury by Inducing Polarization of M2 Subtype Macrophages |
| Q55403102 | Cardiac-derived CTRP9 protects against myocardial ischemia/reperfusion injury via calreticulin-dependent inhibition of apoptosis. |
| Q27027840 | Cardiometabolic effects of adiponectin |
| Q38687619 | Cardiovascular Adiponectin Resistance: The Critical Role of Adiponectin Receptor Modification. |
| Q47145290 | Cbl downregulation increases RBP4 expression in adipocytes of female mice |
| Q34195243 | Change in circulating adiponectin in advanced old age: determinants and impact on physical function and mortality. The Cardiovascular Health Study All Stars Study |
| Q48576993 | Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients |
| Q35806550 | Chemerin15-Ameliorated Cardiac Ischemia-Reperfusion Injury Is Associated with the Induction of Alternatively Activated Macrophages. |
| Q93107247 | Circulating adipokines and metabolic setting in differentiated thyroid cancer |
| Q34364145 | Complement protein C1q and adiponectin stimulate Mer tyrosine kinase-dependent engulfment of apoptotic cells through a shared pathway |
| Q42946774 | Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: Subgroup analysis of JAPAN-ACS study |
| Q33613182 | Cot/tpl2 participates in the activation of macrophages by adiponectin. |
| Q36710970 | Cyclooxygenase-2 induction by adiponectin is regulated by a sphingosine kinase-1 dependent mechanism in cardiac myocytes |
| Q41636688 | Cystatin C-Adiponectin Complex in Plasma Associates with Coronary Plaque Instability |
| Q39250720 | DGAT1-dependent triacylglycerol storage by macrophages protects mice from diet-induced insulin resistance and inflammation. |
| Q24294331 | DIP2A functions as a FSTL1 receptor |
| Q47140339 | Deficiency of CCAAT/enhancer-binding protein homologous protein (CHOP) prevents diet-induced aortic valve calcification in vivo |
| Q38231269 | Dynamic interplay between metabolic syndrome and immunity. |
| Q37325661 | Elevated adiponectin expression promotes adipose tissue vascularity under conditions of diet-induced obesity |
| Q35578295 | Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity? |
| Q30249547 | Emerging role of adipokines in systemic lupus erythematosus |
| Q35601475 | Eosinophils are necessary for pulmonary arterial remodeling in a mouse model of eosinophilic inflammation-induced pulmonary hypertension |
| Q36849638 | Evolving role of adiponectin in cancer-controversies and update |
| Q35131524 | Fish oil N-3 fatty acids increase adiponectin and decrease leptin levels in patients with systemic lupus erythematosus |
| Q37002798 | From regulation of dying cell engulfment to development of anti-cancer therapy |
| Q99613448 | Gene expression of the immunoinflammatory and immunological status of obese dogs before and after weight loss |
| Q56916589 | Globular adiponectin induces leukocytosis and mobilizes hematopoietic progenitor cells in mice |
| Q34055122 | Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions |
| Q38638971 | Immunomodulatory effects of anesthetics in obese patients |
| Q36890479 | Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model |
| Q34184850 | Impact of adiponectin deficiency on pulmonary responses to acute ozone exposure in mice |
| Q38451844 | Inflammation, a link between obesity and atrial fibrillation. |
| Q34118648 | Inhibition of leptin-induced vascular extracellular matrix remodelling by adiponectin |
| Q26997316 | Intracellular nucleic acid sensors and autoimmunity |
| Q54619726 | Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectin-null mice: implications for therapy. |
| Q37513694 | Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis |
| Q36101219 | Leptin, adiponectin and pulmonary diseases |
| Q99561825 | Leptin: Master Regulator of Biological Functions that Affects Breathing |
| Q35211640 | Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: the Cardiovascular Health Study All Stars study |
| Q42947746 | Low Plasma Adiponectin as a Potential Biomarker for Osteonecrosis of the Femoral Head |
| Q36694821 | Low Plasma Levels of Adiponectin Do Not Explain Acute Respiratory Distress Syndrome Risk: a Prospective Cohort Study of Patients with Severe Sepsis. |
| Q33415488 | Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques |
| Q35039346 | Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response |
| Q37597694 | Metabolic function of the CTRP family of hormones. |
| Q34857082 | Modification of the association between PM10 and lung function decline by cadherin 13 polymorphisms in the SAPALDIA cohort: a genome-wide interaction analysis |
| Q40771004 | Modified halloysite nanotubes and the alleviation of kidney damage induced by dietary zearalenone in swine |
| Q36419531 | Modulation of Lupus Phenotype by Adiponectin Deficiency in Autoimmune Mouse Models |
| Q38125279 | Molecular biology of atherosclerosis |
| Q36949870 | Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference |
| Q83227582 | Native adiponectin in serum binds to mammalian cells expressing T-cadherin, but not AdipoRs or calreticulin |
| Q35151051 | Neutrophil clearance: when the party is over, clean-up begins |
| Q88990365 | Novel insights into the role of inflammasomes in autoimmune and metabolic rheumatic diseases |
| Q35896190 | Obesity and pulmonary arterial hypertension: Is adiponectin the molecular link between these conditions? |
| Q30417265 | Obesity and respiratory infections: does excess adiposity weigh down host defense? |
| Q38189680 | Obesity as a risk factor for Alzheimer's disease: the role of adipocytokines |
| Q33728020 | Obesity, adipokines, and lung disease |
| Q36951691 | Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. |
| Q27012995 | Obesity: "priming" the lung for injury |
| Q39549749 | Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial. |
| Q58327102 | Paradoxical role for adiponectin in chronic renal diseases? An example of reverse epidemiology |
| Q36850779 | Pathophysiological significance of adiponectin |
| Q37640810 | Phagocytic clearance of apoptotic cells: role in lung disease |
| Q43769000 | Plasma adiponectin levels for prediction of cardiovascular risk among hemodialysis patients |
| Q35088793 | Positive feedback regulation between adiponectin and T-cadherin impacts adiponectin levels in tissue and plasma of male mice |
| Q37608586 | Potential of adiponectin as a cardioprotective agent |
| Q39574974 | Protective effects of adiponectin against renal ischemia-reperfusion injury via prostacyclin-PPARα-heme oxygenase-1 signaling pathway |
| Q64255446 | Pulmonary Hypertension and Obesity: Focus on Adiponectin |
| Q46288120 | Reply to letter to the editor: adiponectin levels in hemodialysis patients |
| Q38252969 | Role of adiponectin system in insulin resistance |
| Q34345652 | Role of the adiponectin binding protein, T-cadherin (Cdh13), in allergic airways responses in mice |
| Q34766769 | Role of the adiponectin binding protein, T-cadherin (cdh13), in pulmonary responses to subacute ozone |
| Q35623130 | Sensors of the innate immune system: their link to rheumatic diseases |
| Q34461600 | Serum adiponectin is positively associated with lung function in young adults, independent of obesity: the CARDIA study |
| Q35101405 | Serum adiponectin levels in advanced-stage Parkinson's disease patients |
| Q27339594 | Shared epitope-antagonistic ligands: a new therapeutic strategy in mice with erosive arthritis. |
| Q34348612 | Signaling through LRP1: Protection from atherosclerosis and beyond |
| Q46974153 | Statin reverses reduction of adiponectin receptor expression in infarcted heart and in TNF-alpha-treated cardiomyocytes in association with improved glucose uptake |
| Q34365487 | Study of adiponectin in chronic liver disease and cholestasis |
| Q37739296 | Sustained High Levels of Both Total and High Molecular Weight Adiponectin in Plasma during the Convalescent Phase of Haemorrhagic Fever with Renal Syndrome Are Associated with Disease Severity |
| Q35173604 | Systemic adiponectin malfunction as a risk factor for cardiovascular disease |
| Q34793130 | T-cadherin is essential for adiponectin-mediated revascularization |
| Q36811126 | TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity |
| Q61448813 | The Role of Leptin and Adiponectin in Obesity-Associated Cognitive Decline and Alzheimer's Disease |
| Q36633255 | The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy |
| Q38915167 | The evolving role of adiponectin as an additive biomarker in HFrEF. |
| Q37161474 | The link between abdominal obesity and the metabolic syndrome |
| Q27012666 | The pathophysiology of abdominal adipose tissue depots in health and disease |
| Q28585701 | The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin |
| Q34271986 | The role of adiponectin in cancer: a review of current evidence |
| Q36555556 | Thiazolidinediones reduce pathological neovascularization in ischemic retina via an adiponectin-dependent mechanism |
| Q24316639 | Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis |
| Q37693053 | Tight association between macrophages and adipocytes in obesity: implications for adipocyte preparation |
| Q36508893 | Total and high-molecular-weight adiponectin and risk of coronary heart disease and ischemic stroke in older adults |
| Q33724020 | Tracing the movement of adiponectin in a parabiosis model of wild-type and adiponectin-knockout mice |
| Q35073031 | Transcriptional regulation of an insulin-sensitizing adipokine adipolin/CTRP12 in adipocytes by Krüppel-like factor 15. |
| Q33581743 | Ultrastructural localization of adiponectin protein in vasculature of normal and atherosclerotic mice |
| Q33690051 | Upregulation of Early and Downregulation of Terminal Pathway Complement Genes in Subcutaneous Adipose Tissue and Adipocytes in Acquired Obesity |
| Q85054849 | [Systemic lupus erythematosus: from pathophysiology to treatment] |
Search more.